Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-15
DOI
10.1038/s41375-022-01618-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating Tumor DNA Predicts Therapeutic Outcome in Mantle Cell Lymphoma
- (2022) Rahul Lakhotia et al. Blood Advances
- The many facets of liquid biopsies in lymphoma
- (2022) David M. Kurtz BLOOD
- Inferring gene expression from cell-free DNA fragmentation profiles
- (2022) Mohammad Shahrokh Esfahani et al. NATURE BIOTECHNOLOGY
- Circulating tumour DNA in B‐cell lymphomas: current state and future prospects
- (2021) Rahul Lakhotia et al. BRITISH JOURNAL OF HAEMATOLOGY
- MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
- (2021) Andrés J. M. Ferreri et al. BRITISH JOURNAL OF HAEMATOLOGY
- ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
- (2021) Grzegorz S. Nowakowski et al. JOURNAL OF CLINICAL ONCOLOGY
- A Rapid Genotyping Panel for Detection of Primary Central Nervous System Lymphoma
- (2021) Mihir Gupta et al. BLOOD
- Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma
- (2021) Stefan Alig et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffuse large B-cell lymphoma: new targets and novel therapies
- (2021) Bruce D. Cheson et al. Blood Cancer Journal
- DETERMINANTS OF RESISTANCE TO ENGINEERED T‐CELL THERAPIES TARGETING CD19 IN LYMPHOMA
- (2021) B Sworder et al. HEMATOLOGICAL ONCOLOGY
- NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICATION OF PRIMARY CNS LYMPHOMAS BY CTDNA PROFILING
- (2021) J. A. Mutter et al. HEMATOLOGICAL ONCOLOGY
- PHASED VARIANTS IMPROVE DLBCL MINIMAL RESIDUAL DISEASE DETECTION AT THE END OF THERAPY
- (2021) D. M Kurtz et al. HEMATOLOGICAL ONCOLOGY
- Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial
- (2021) Matthew J. Frank et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
- (2021) David M. Kurtz et al. NATURE BIOTECHNOLOGY
- Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL
- (2021) Alexander Baraniskin et al. Cancers
- Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
- (2021) Adam J Olszewski et al. Blood Advances
- Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma
- (2021) Jurik Andreas Mutter et al. BLOOD
- A Prospective Study of Clonal Evolution in Follicular Lymphoma: Circulating Tumor DNA Correlates with Overall Tumor Burden and Fluctuates over Time without Therapy
- (2021) Allison Distler et al. BLOOD
- Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
- (2021) Leo Meriranta et al. BLOOD
- A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma
- (2021) Anita Kumar et al. BLOOD
- Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
- (2021) Frederick L. Locke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minimal Residual Disease (MRD) Assessment in the ECOG1411 Randomized Phase 2 Trial of Front-Line Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma (MCL)
- (2020) Mitchell Smith et al. BLOOD
- Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
- (2020) Sabela Bobillo et al. HAEMATOLOGICA
- Targeted genotyping of circulating tumor DNA for classical Hodgkin Lymphoma monitoring: a prospective study
- (2020) Vincent Camus et al. HAEMATOLOGICA
- Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
- (2020) Christopher G. Smith et al. Genome Medicine
- Integrating genomic features for non-invasive early lung cancer detection
- (2020) Jacob J. Chabon et al. NATURE
- Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
- (2020) Pier Vitale Nuzzo et al. NATURE MEDICINE
- Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma
- (2020) Ákos Nagy et al. Genes
- Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management
- (2020) Julius Wehrle et al. Diagnostics
- Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
- (2020) Christopher K. Rushton et al. Blood Advances
- Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
- (2020) Franck Morschhauser et al. LANCET ONCOLOGY
- Liquid biopsy approaches for pleural effusion in lung cancer patients
- (2020) Gayathri Baburaj et al. MOLECULAR BIOLOGY REPORTS
- Frequent Genetic Alterations in Immune Checkpoint-Related Genes in Intravascular Large B-Cell Lymphoma
- (2020) Kazuyuki Shimada et al. BLOOD
- Liquid biopsy in lymphoma: Molecular methods and clinical applications
- (2020) Melita Cirillo et al. CANCER TREATMENT REVIEWS
- The role of PET in first-line treatment of Hodgkin lymphoma
- (2020) Judith Trotman et al. Lancet Haematology
- Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma
- (2019) Anas Younes et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
- (2019) Anne-Katrin Hickmann et al. BMC CANCER
- Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction
- (2019) David M. Kurtz et al. CELL
- Liquid biopsy in non‐Hodgkin's lymphoma
- (2019) Christopher Melani et al. HEMATOLOGICAL ONCOLOGY
- Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma
- (2019) Jun Watanabe et al. LEUKEMIA & LYMPHOMA
- MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial
- (2019) Christiane Pott et al. LEUKEMIA
- Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma
- (2019) Ann-Kathrin Desch et al. LEUKEMIA
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15‐ICML workshop on ctDNA
- (2019) Davide Rossi et al. HEMATOLOGICAL ONCOLOGY
- Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
- (2018) Valeria Spina et al. BLOOD
- Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects
- (2018) Oshrat Hershkovitz-Rokah et al. BRITISH JOURNAL OF HAEMATOLOGY
- Liquid biopsy for the identification of intravascular large B-cell lymphoma
- (2018) Yasuhito Suehara et al. HAEMATOLOGICA
- Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
- (2018) Ulrich Dührsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
- (2018) Bjoern Chapuy et al. NATURE MEDICINE
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
- (2018) Roland Schmitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
- (2018) Constantine S. Tam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liquid biopsy for the identification of intravascular large B-cell lymphoma
- (2018) Yasuhito Suehara et al. HAEMATOLOGICA
- Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
- (2018) David M. Kurtz et al. JOURNAL OF CLINICAL ONCOLOGY
- Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
- (2018) Elodie Bohers et al. Blood Cancer Journal
- Phase Ib trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
- (2018) Christian Grommes et al. BLOOD
- MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma
- (2018) Laura S. Hiemcke-Jiwa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
- (2018) Rishu Agarwal et al. NATURE MEDICINE
- Detection and surveillance of bladder cancer using urine tumor DNA
- (2018) Jonathan C. Dudley et al. Cancer Discovery
- The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid
- (2017) Laura S. Hiemcke-Jiwa et al. HEMATOLOGICAL ONCOLOGY
- Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma
- (2017) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
- (2017) Annalisa Chiappella et al. LANCET ONCOLOGY
- The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma
- (2017) Clémentine Sarkozy et al. Oncotarget
- Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma
- (2017) Maxime Fontanilles et al. Oncotarget
- Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
- (2016) S. E. Assouline et al. BLOOD
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- (2016) Mark Hertzberg et al. HAEMATOLOGICA
- Integrated digital error suppression for improved detection of circulating tumor DNA
- (2016) Aaron M Newman et al. NATURE BIOTECHNOLOGY
- Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
- (2016) F. Scherer et al. Science Translational Medicine
- Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
- (2016) Chenglin Wu et al. Oncotarget
- Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones
- (2016) Thomas Melchardt et al. Oncotarget
- Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study
- (2016) Robert Kridel et al. PLOS MEDICINE
- Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma
- (2016) V. Camus et al. HAEMATOLOGICA
- Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
- (2016) Mark Hertzberg et al. HAEMATOLOGICA
- Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
- (2015) D. M. Kurtz et al. BLOOD
- Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)
- (2015) Lode J. Swinnen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission
- (2015) Scott F. Huntington et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
- (2015) Mark Roschewski et al. LANCET ONCOLOGY
- Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation
- (2015) Florian Scherer et al. LEUKEMIA & LYMPHOMA
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
- (2015) Wyndham H Wilson et al. NATURE MEDICINE
- Complications Following Stereotactic Needle Biopsy of Intracranial Tumors
- (2015) Hani Malone et al. World Neurosurgery
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
- (2014) Myriam Sasanelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma
- (2014) Carrie A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
- (2014) Aaron M Newman et al. NATURE MEDICINE
- Detecting ultralow-frequency mutations by Duplex Sequencing
- (2014) Scott R Kennedy et al. Nature Protocols
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of Follicular Lymphoma Transformation
- (2014) Laura Pasqualucci et al. Cell Reports
- Utility of Flow Cytometry of Cerebrospinal Fluid as a Screening Tool in the Diagnosis of Central Nervous System Lymphoma
- (2013) Meredith Pittman et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma
- (2013) Patrick J. Stiff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenesis of follicular lymphoma
- (2012) Robert Kridel et al. JOURNAL OF CLINICAL INVESTIGATION
- Detection of ultra-rare mutations by next-generation sequencing
- (2012) M. W. Schmitt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium
- (2011) G. Salles et al. BLOOD
- Transformation of Indolent B-Cell Lymphomas
- (2011) Silvia Montoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
- (2010) Craig H. Moskowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
- (2007) E. Hoster et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now